CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $158,000 | -15.5% | 6,163 | -21.8% | 0.00% | – |
Q2 2022 | $187,000 | -12.6% | 7,877 | -17.1% | 0.00% | – |
Q1 2022 | $214,000 | -71.3% | 9,506 | -74.8% | 0.00% | -100.0% |
Q4 2021 | $746,000 | -48.8% | 37,696 | -49.1% | 0.00% | -66.7% |
Q3 2021 | $1,456,000 | -73.3% | 74,000 | -70.2% | 0.00% | -66.7% |
Q2 2021 | $5,458,000 | -41.8% | 248,100 | -37.0% | 0.01% | -43.8% |
Q1 2021 | $9,370,000 | -50.3% | 393,900 | -45.3% | 0.02% | -52.9% |
Q4 2020 | $18,845,000 | -31.7% | 720,400 | -54.5% | 0.03% | -39.3% |
Q3 2020 | $27,585,000 | -0.0% | 1,584,900 | -3.4% | 0.06% | -1.8% |
Q2 2020 | $27,586,000 | +23.2% | 1,640,081 | -12.9% | 0.06% | +5.6% |
Q1 2020 | $22,396,000 | +7.7% | 1,883,624 | +9.6% | 0.05% | +68.8% |
Q4 2019 | $20,792,000 | +35.0% | 1,718,424 | +57.7% | 0.03% | +28.0% |
Q3 2019 | $15,398,000 | +148.8% | 1,089,386 | +96.3% | 0.02% | +150.0% |
Q2 2019 | $6,189,000 | +367.1% | 555,100 | +391.7% | 0.01% | +400.0% |
Q1 2019 | $1,325,000 | -12.1% | 112,900 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $1,508,000 | – | 112,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |